Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Health officials have warned victims of diabetes against certain drugs that have proved to trigger pancreatitis! Medical reports 2013 have underlined the existence of some diabetes drugs which has as aim to lower blood sugar levels, may be at an increased risk of developing an inflamed pancreas! In-depth reports have demonstrated that the Glucagonlike peptide 1(GLP-1) therapies that include exenatide - marketed as Byetta by an alliance between Bristol-Myers Squibb and AstraZeneca - and sitagliptin - marketed as Januvia by Merck - have been linked to pancreatitis. Medical scientists have highlighted that pancreatitis has the potential to cause life-threatening complications. Despite being rare, pancreatitis is very often detected among people with type 2 diabetes. According to medical surveys, 3 in very 1, 000 diabetes patients do develop pancreatitis...
|Author||Edward R. Miller-Jones|
|Number of Pages||140|
|Country of Manufacture||India|
|Product Brand||FastBook Publishing|
|Product Packaging Info||Box|
|In The Box||1 Piece|
|Product First Available On ClickOnCare.com||2015-10-08 00:00:00|